Structure

InChI Key CTENFNNZBMHDDG-UHFFFAOYSA-N
Smile Cl.NCCc1ccc(O)c(O)c1
InChI
InChI=1S/C8H11NO2.ClH/c9-4-3-6-1-2-7(10)8(11)5-6;/h1-2,5,10-11H,3-4,9H2;1H

Physicochemical Descriptors

Property Name Value
Molecular Formula C8H12ClNO2
Molecular Weight 189.64
AlogP 0.6
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 2.0
Polar Surface Area 66.48
Molecular species BASE
Aromatic Rings 1.0
Heavy Atoms 11.0

Pharmacology

Action Mechanism of Action Reference
AGONIST Beta-1 adrenergic receptor agonist DailyMed Wikipedia

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Parkinson Disease 3 D010300 ClinicalTrials

Related Entries

Parent

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
15.88
Vascular disorders
15.44
Cardiac disorders
14.88
Investigations
7.85
Immune system disorders
6.6
Injury, poisoning and procedural complications
6.04
Nervous system disorders
5.92
Respiratory, thoracic and mediastinal disorders
5.6
Skin and subcutaneous tissue disorders
4.48
Pregnancy, puerperium and perinatal conditions
2.74
Gastrointestinal disorders
2.3

Cross References

Resources Reference
ChEBI 4698
ChEMBL CHEMBL1557
EPA CompTox DTXSID7020550
FDA SRS 7L3E358N9L
Guide to Pharmacology 940
KEGG C03758
PDB LDP
PubChem 65340
SureChEMBL SCHEMBL40951
ZINC ZINC00033882